Roche Holding AG (ROG.SW) SIX
322.30
+1.6(+0.50%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
Roche Holding AG
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
103249
First IPO Date
August 03, 1995
Key Executives
| Name | Title | Pay | Year Born |
| Thomas Schinecker | Group Chief Executive Officer | 3.87M | 1975 |
| Maria Cristina A. Wilbur | Chief People Officer | 2.92M | 1967 |
| Alan Hippe | Chief Financial Officer | 4.11M | 1967 |
| Severin Schwan | Executive Chairman | 7.51M | 1967 |
| Chris Brittain | Global Head of Ophthalmology Product Development & Vice President | 0 | N/A |
| Aviv Regev | Head of Genentech Research & Early Development (gRED) | 0 | 1971 |
| Levi Garraway | Executive VP, Head of Global Product Development & Chief Medical Officer | 0 | 1969 |
| Nina Schwab-Hautzinger | Head of Group Communications | 0 | 1975 |
| John Young | Global Head of Infectious Diseases of Roche Pharma Research & Early Development | 0 | N/A |
| Ann Costello | Global Head of Roche Diagnostics Solutions | 0 | N/A |
| Jill German | President of Roche Tissue Diagnostics | 0 | N/A |
| Pascale Schmidt | Chief Compliance Officer | 0 | 1973 |
| Palani Kumaresan | Head of Research & Development - Roche Diagnostics | 0 | N/A |
| Bruno Eschli | Head of Investor Relations | 0 | N/A |
| Nicolas Dunant | Head of Group Media Relations | 0 | N/A |
| Barbara Schadler | Head of Group Communications | 0 | 1962 |
| Claudia Bockstiegel | General Counsel | 0 | 1964 |
| Boris L. Zaitra | Head of Corporate Business Development | 0 | 1972 |
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
